NYSE: APUS
Application of Bee Venom to the treatment of inflammatory conditions, beginning with Knee OA and Multiple Sclerosis.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 100 Matawan Rd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.apimedsus.com
- Keywords
- San Francisco.
- HQ
- Matawan, New Jersey
Apimeds Pharmaceuticals Us (Nyse:apus) Questions
Apimeds Pharmaceuticals Us (Nyse:Apus)'s website is http://www.apimedsus.com
Apimeds Pharmaceuticals Us (Nyse:Apus)'s LinkedIn profile is https://www.linkedin.com/company/apimedsus
Apimeds Pharmaceuticals Us (Nyse:Apus) has
6 employees.
View email and phone details for 6
employees at Apimeds Pharmaceuticals Us (Nyse:Apus).
Apimeds Pharmaceuticals Us (Nyse:Apus)'s industry is
Biotechnology Research
Apimeds Pharmaceuticals Us (Nyse:Apus)'s top competitors are
Divergence Labs,
Immuron,
Bright Green Corporation,
Advanced Biomedical,
Odyssey Health Inc.,
Ptls Hope Research Foundation,
Corcept Therapeutics,
Septerna,
The Collaboratory Agency,
Apimed Pharmaceutical Jsc.
Apimeds Pharmaceuticals Us (Nyse:Apus)'s categories are Biotechnology Research
Apimeds Pharmaceuticals Us (Nyse:Apus)'s founding year is 2020
